Mammotome Prima™ MR System
Introducing a dedicated solution for MR, both biopsy system and marker. The unique combination of the Mammotome Prima™ MR system and HydroMARK™ Plus marker provides greater confidence during MR-guided breast biopsies.1
Mammotome Revolve™ ST Breast Biopsy System
The Mammotome Revolve™ ST system is compatible with all leading stereo biopsy-capable imaging.
Pintuition® System Now in Canada
Designed to provide Surgical Marker Navigation in an easy-to-use and intuitive system.
Smart Size. Smart Choice.
Now offering two 10mm gamma detection probes2
Products & Solutions
At Mammotome, we are committed to providing best-in-class technology to help clinicians accurately diagnose breast cancer. Never forgetting that at the heart of each breast cancer diagnosis is the patient. Our product portfolio covers two integrated main steps in the overall breast cancer treatment pathway: breast biopsy and local surgical treatments.
Neoprobe® Gamma Detection System
Neoprobe® GDS offers exceptional accuracy, effortless operation and advanced clinical capability.
Mammotome Prima™ MR System
The first ever in-room, vacuum-assisted MR breast biopsy system at the patient’s side to improve clinician coordination, communication, and patient focus.
Pintuition® System
Designed to provide surgical marker navigation in an easy-to-use and intuitive system
Mammotome® Markers
Mammotome® Markers offer clinicians the most comprehensive portfolio available, providing a customized solution for every breast biopsy need.
Mammotome® Elite System
The Mammotome® Elite breast biopsy device combines vacuum-assisted biopsy tissue quality with the ease and speed of a spring-loaded core needle.
Mammotome DualCore™ System
Lightweight, precise, and reliable, offering a spring-loaded action for quality sampling capability.
Mammotome Service and Support
Service and support from the team that knows your Mammotome products best.
Mammotome Revolve™ System
Redefining procedural efficiency without compromising tissue quality – from positioning to diagnosis.
Mammotome Confirm™ SRS
Verify the presence of microcalcifications during stereotactic biopsies quickly and easily.
XPERT® 40 SRS
When you need to identify fine details, in a wide range of specimens, in a short amount of time.
1. HydroMARK™ Plus Device Test - PCR-000979 Summative, ES-002827 Claims Assessment
2. Only available in the U.S. with other country registrations pending.
Upcoming Events & Initiatives
Mammotome Advances Surgical Precision with 10mm Probes for the Neoprobe® Gamma Detection System
Mammotome is proud to unveil exciting enhancements to its trusted Neoprobe® Gamma Detection System (GDS).
Mammotome Secures FDA Clearance for the Mammotome Prima™ MR System and New HydroMARK™ Plus MR Biopsy Site Markers
Mammotome announces FDA Clearance of two innovations for MR-guided breast biopsy
Sirius Medical and Mammotome Announce Health Canada Approval for The Pintuition® System
Mammotome and Sirius Medical announce Health Canada approval for the Pintuition® System, expanding access across the country.
About Us
At Mammotome, we are a global team dedicated to advancing breast care. Our passion is driving innovative technologies that create efficiencies for clinicians, while never forgetting that at the heart of every breast cancer journey is a patient.
Learn how we transformed the future of breast cancer diagnostics and continue to discover new opportunities to deliver better solutions and care.
550+
Dedicated
Associates
9
Global
Locations
60
Countries
Where Our Products Are Sold
Join the Team
Mammotome associates know that every moment matters when it comes to advancing breast cancer diagnostics and surgical solutions. We’re a global team of engineers, designers, communicators, strategists and specialists focused on improving patient outcomes. Inspired to grow every day, our collaborative, diverse, high-performing team is a trusted leader in the breast care industry. And as part of Danaher, we’re growing fast and innovating faster.
